CIK 0001087294
- Non-accelerated filer
- Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- Operating
- EIN
- 621765329
- Phone
- +1 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Chief Financial Officer bought 900 shares at $5.50 ($4,950)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 3,000 shares at $4.60 ($13,800)
- 4 Shares withheld for taxes VP and Chief Compliance Office gave up 3,840 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and Chief Development Off. gave up 7,296 shares (to pay taxes)
- 4 Shares withheld for taxes Sr VP/Chief Commercial Officer gave up 3,960 shares (to pay taxes)
- 4 Shares withheld for taxes Chairman and CEO gave up 3,802 shares (to pay taxes)
- 4 Open-market sale Director sold 3,000 shares at $4.55 ($13,650)
- 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 4,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 2,750 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Open-market sale Director sold 5,000 shares at $4.34 ($21,700)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 19 of 26 · 512 filings